Loading...
Market
Will the FDA approve a therapy based on reprogrammed brain cells by end of 2026?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA official announcements and approval records
Story
Reprogrammed Brain Cells Could Restore Damaged Circuits, Specific Interneurons
Nov 11, 2024, 04:15 PM
Researchers have successfully reprogrammed brain support cells called astroglia into neuron-like cells that mimic specific interneurons vital for brain functions. This study, focusing on regenerative medicine, could potentially restore damaged brain circuits. Additionally, new research shows that astrocytes, non-neuronal brain cells, help determine whether memories are stored long-term or forgotten. In mice, acidifying astrocytes shortly after a traumatic event led to the memory fading within a short period.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Full Approval • 25%
Accelerated Approval • 25%
Conditional Approval • 25%
Rejection • 25%
